Skip to content

Noah Goodman, Chief Business Officer at Kymera Therapeutics, sold KYMR on Jun 25, 2026

Data as of Oct 16

▼ SELL$298K2,500 shares at $119.00Noah Goodman Chief Business OfficerKYMR Kymera Therapeutics, Inc.
Watch KYMR
Traded
Jun 25, 2026
Disclosed
Jun 25, 2026
Filed
The same day

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Noah Goodman, Chief Business Officer at Kymera Therapeutics, sold KYMR on Jun 25, 2026TRADEDDISCLOSED
KYMRSimilar stocks (XLV — its sector index fund), rebased to KYMR's price on the disclosure day
KYMR since disclosure
−10.0%
after the sale
Similar stocks (XLV) since disclosure
+13.5%
XLV — its sector index fund

Change in closing price from Jun 25, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLNoah Goodman Chief Business OfficerKYMR Kymera Therapeutics, Inc.$273Kdisclosed Jun 25 · filed the same day

See every trade on KYMR →